From the AMCP Policy Digest, AMCP's policies regarding patient confidentiality.
AMCP Position Statements
See how AMCP advocates for you. Stay informed on the latest policy actions and position statements shaping legislation and pharmacy practice so you can understand what’s changing and why it matters for your work in managed care pharmacy.
Shaping Practice Standards in Managed Care Pharmacy
AMCP’s nearly 8,000 members work to improve the health of more than 200 million Americans through managed care pharmacy. Our Position Statements reflect AMCP’s stance on key professional and practice issues, guiding members in their roles and supporting advocacy with policymakers and stakeholders. Approved by the AMCP Board of Directors, these concise statements help define the responsibilities of managed care pharmacists, ensuring medications are used safely, effectively, and affordably.
From the AMCP Policy Digest, AMCP's policies regarding health information and automation technology.
From the AMCP Policy Digest, AMCP's policies regarding workforce issues.
From the AMCP Policy Digest, AMCP's policies regarding drug integrity issues.
From the AMCP Policy Digest, AMCP's policies regarding pharmacy practice issues.
From the AMCP Policy Digest, AMCP's policies regarding managed care pharmacy tools.
AMCP believes that payors must have the flexibility to use mail service delivery of prescription drugs as a component of their prescription drug benefit.
AMCP supports the use of value frameworks as a resource for determining the value of pharmaceuticals and other health technologies when the Frameworks are based on sound methods using good scientific evidence and economic models.
AMCP believes that plan participants are able to exercise freedom of choice without any willing provider mandates
AMCP supports efforts to encourage transparency within health care. This statement focuses on how transparency applies to the use of prescription information, drug costs and communication.
AMCP recognizes that many patients today depend on high‐cost specialty medications that often do not have therapeutic alternatives. Medication cost-share offset programs provide out-of-pocket discounts or free product at the point of sale. AMCP is concerned that certain cost‐share offset programs may undermine formulary development and utilization management techniques and can also increase costs for health plans and, ultimately, patients themselves.
AMCP does not support direct‐to‐consumer advertising that promotes specific prescription drug products, however we do support advertisements that educate the public about disease symptoms and available treatment options.
